- Home
- CCG vs MCRB Comparison
CCG vs MCRB Comparison
Compare CCG & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- MCRB
- Stock Information
- Founded
- CCG 2014
- MCRB 2010
- Country
- CCG China
- MCRB United States
- Employees
- CCG N/A
- MCRB N/A
- Industry
- CCG
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- CCG
- MCRB Health Care
- Exchange
- CCG Nasdaq
- MCRB Nasdaq
- Market Cap
- CCG 68.6M
- MCRB 72.0M
- IPO Year
- CCG N/A
- MCRB 2015
- Fundamental
- Price
- CCG $0.82
- MCRB $7.05
- Analyst Decision
- CCG
- MCRB Hold
- Analyst Count
- CCG 0
- MCRB 5
- Target Price
- CCG N/A
- MCRB $73.67
- AVG Volume (30 Days)
- CCG 170.1K
- MCRB 93.5K
- Earning Date
- CCG 06-06-2025
- MCRB 05-07-2025
- Dividend Yield
- CCG N/A
- MCRB N/A
- EPS Growth
- CCG N/A
- MCRB N/A
- EPS
- CCG N/A
- MCRB 8.98
- Revenue
- CCG $475,831,129.00
- MCRB N/A
- Revenue This Year
- CCG N/A
- MCRB N/A
- Revenue Next Year
- CCG $7.06
- MCRB N/A
- P/E Ratio
- CCG N/A
- MCRB $0.84
- Revenue Growth
- CCG 5.20
- MCRB N/A
- 52 Week Low
- CCG $0.56
- MCRB $6.53
- 52 Week High
- CCG $1.57
- MCRB $30.60
- Technical
- Relative Strength Index (RSI)
- CCG 46.18
- MCRB 38.95
- Support Level
- CCG $0.78
- MCRB $7.32
- Resistance Level
- CCG $0.84
- MCRB $7.86
- Average True Range (ATR)
- CCG 0.03
- MCRB 0.63
- MACD
- CCG 0.00
- MCRB 0.10
- Stochastic Oscillator
- CCG 48.20
- MCRB 28.89
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.